XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Cash flows from operating activities      
Net loss $ (14,850,591) $ (3,949,294)  
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 546,913 228,538  
Noncash interest expense 939,919 4,397  
Noncash interest income (87,233)  
Stock compensation expense 189,670 79,740  
Inducement expense related to warrant reprice 7,755,541  
Change in fair value of derivative liabilities 101,390  
Impairment of right-of-use asset 55,496  
Impairment of intangible assets 750,596  
Changes in operating assets and liabilities      
Accounts receivable 155,689 401,532  
Inventory (448,486) 36,257  
Other assets 210,102 283,180  
Accounts payable (570,922) (627)  
Accrued compensation and other liabilities 949,351 (91,828)  
Net cash used in operating activities (4,965,928) (2,344,742)  
Cash flows from investing activities      
Note receivable (2,200,000)  
Purchases of property and equipment (850,885) (1,057)  
Net cash used in investing activities (850,885) (2,201,057)  
Cash flows from financing activities      
Proceeds from issuance of common stock, net of issuance costs 5,477,432  
Proceeds from issuance of common stock warrants 255,751  
Proceeds from issuance of common stock and pre-funded warrants in registered offering, net of selling costs 23,473,962  
Proceeds from the exercise of common stock warrants, net of issuance costs 9,094,172 8,142,000  
Payments on debt (418,374) (191,772)  
Payments on finance lease obligations (100,466) (162,453)  
Net cash provided by financing activities 32,305,045 13,265,207  
Effects of exchange rates on cash (628,998) 41,824  
Net increase in cash and cash equivalents and restricted cash 25,859,234 8,761,232  
Cash and cash equivalents and restricted cash at beginning of period 14,107,255 2,893,603 $ 2,893,603
Cash and cash equivalents and restricted cash at end of period 39,966,489 11,654,835 $ 14,107,255
Supplemental disclosure of cash flow information      
Cash paid for interest 26,029 55,011  
Supplemental disclosures of noncash investing and financing activities      
Right-of-use assets acquired through operating leases $ 748,294